All cancer types, Mesothelioma, Secondary cancers
Results
Phase 1
This trial looked at a drug called GSK2256098 alongside trametinib for solid tumours that are not responding to other treatments. A solid tumour is any cancer except lymphoma, leukaemia and myeloma.
People could join the trial between 2013 and 2016. The team published the results in 2019.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 7 November 2013
Recruitment end: 24 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tobias Arkenau
GlaxoSmithKline (GSK)
Last reviewed: 08 Oct 2026
CRUK internal database number: 12162
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
